PMV Pharmaceuticals
PMVP
PMVP
98 hedge funds and large institutions have $145M invested in PMV Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
20.31% less ownership
Funds ownership: 111.92% → 91.61% (-20%)
56% less capital invested
Capital invested by funds: $333M → $145M (-$188M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
98
Holding in Top 10
1
Calls
$541K
Puts
$58K
Top Buyers
| 1 | +$7.58M | |
| 2 | +$4M | |
| 3 | +$2.38M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.33M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$2.17M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$18.4M | |
| 3 | -$14.6M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$5.55M |
| 5 |
TLP
Tri Locum Partners
New York
|
-$5.04M |